Gyrodyne
GYRO
10 hedge funds and large institutions have $7.58M invested in Gyrodyne in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
10% more capital invested
Capital invested by funds: $6.92M → $7.58M (+$661K)
3.82% more ownership
Funds ownership: 34.88% → 38.7% (+3.8%)
9% less funds holding
Funds holding: 11 → 10 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gabelli Funds
Rye,
New York
|
+$504K |
| 2 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$238K |
| 3 |
TA
Teton Advisors
Rye,
New York
|
+$13.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$301 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 2 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$6.63K |
GYRO Hedge Fund Activity: Q3 2021 in Review
10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Gyrodyne (GYRO) for Q3 2021, worth a combined $7.58M — up 9.5% from $6.92M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GYRO and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was Gabelli Funds, adding an estimated $504K. The largest seller was UBS Group, exiting entirely with an estimated $9K sold.
- 10 institutional investors held Gyrodyne (GYRO) as of Q3 2021, down from 11 in Q2 2021.
- Funds reported $7.58M of Gyrodyne stock for Q3 2021, up 9.5% quarter-over-quarter.
- 0 funds opened new Gyrodyne positions in Q3 2021 and 1 closed out, a net change of -1 holder.
- The largest Gyrodyne buyer in Q3 2021 was Gabelli Funds, an estimated $504K added.
- The largest Gyrodyne seller in Q3 2021 was UBS Group, an estimated $9K sold.
Based on aggregated 13F filings for Q3 2021.